On April 20, 2023, PanGen Biotech Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,700 KRW | 0.00% | -3.88% | -17.15% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
38,050 KRW | -1.93% | -3.43% | 2.51B | ||
5,700 KRW | 0.00% | -3.88% | 48.08M | ||
4,085 KRW | 0.00% | -2.85% | 277M | ||
1st Jan change | Capi. | |
---|---|---|
-17.15% | 48.08M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+28.31% | 12.16B | |
+24.73% | 12.17B |
- Stock Market
- Equities
- A222110 Stock
- News PanGen Biotech Inc.
- PanGen Biotech Inc. announced that it has received KRW 3.2 billion in funding from Eugene Investment & Securities Co.,Ltd., Samsung Securities Co., Ltd.